ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Oral Presentation
Chairs: P. Kirkham (Wolverhampton, United Kingdom), N. Frossard (Illkirch, France)

Late Breaking Abstract - Blood eosinophils in inhaled steroid dose titration S. Jabbal (Dundee, United Kingdom)
Effects of CHF6297, a potent and selective p38a MAPK inhibitor, in murine models of steroid resistant lung inflammation C. Martucci (PARMA, PR, Italy)
Effects of phosphodiesterase inhibitors on the lung functions in a saline lavage-induced model of acute lung injury P. Kosutova (Martin, Slovakia)
Roflumilast N- oxide combined with sildenafil reverses cellular remodeling on IPF models S. Contreras (VALENCIA, Spain)
Modulation of pro-inflammatory and anti-viral responses in BEAS2B cells by glucocorticoid agonists A. Marcellini (FERRARA, Italy)
Imatinib-loaded gold nanoparticles ameliorate experimental lung fibrosis induced by bleomycin
Evaluation of a selective 5-hydroxytryptamine 2B receptor antagonist designed to alter the fibrotic process C. Wenglén (Lund, Sweden)
Assessing the synergistic effect of the enhancer compound HT61 on Tobramycin activity in a murine model of pulmonary infection B. O'Shaughnessy (London, United Kingdom)